Genitourinary Syndrome of Menopause (GSM) is a clinical term for a collection of symptoms caused by decreasing estrogen levels in the vaginal and urinary tissues. This syndrome encompasses vaginal atrophy, which is the thinning, drying, and loss of elasticity of vaginal tissues, and may lead to symptoms like burning, itching, and pain during sexual intercourse (dyspareunia). Urinary symptoms are also a key component of GSM and can include a sudden, pressing need to urinate, leakage during activities like exercise or sneezing (stress incontinence), and an increased risk of urinary tract infections (UTIs). Promoting the use of the term GSM is a significant clinical step, as it validates the connection between these symptoms and encourages a more comprehensive approach to treatment.